Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 734

1.

Joint associations of β-amyloidosis and cortical thickness with cognition.

Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC, Jack CR Jr..

Neurobiol Aging. 2018 Feb 2;65:121-131. doi: 10.1016/j.neurobiolaging.2018.01.017. [Epub ahead of print]

PMID:
29471214
2.

A comparison of manual tracing and FreeSurfer for estimating hippocampal volume over the adult lifespan.

Schmidt MF, Storrs JM, Freeman KB, Jack CR Jr, Turner ST, Griswold ME, Mosley TH Jr.

Hum Brain Mapp. 2018 Feb 21. doi: 10.1002/hbm.24017. [Epub ahead of print]

PMID:
29468773
3.

[18F]AV-1451 tau-PET and primary progressive aphasia.

Josephs KA, Martin PR, Botha H, Schwarz CG, Duffy JR, Clark HM, Machulda MM, Graff-Radford J, Weigand SD, Senjem ML, Utianski RL, Drubach DA, Boeve BF, Jones DT, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Whitwell JL.

Ann Neurol. 2018 Feb 16. doi: 10.1002/ana.25183. [Epub ahead of print]

PMID:
29451323
4.

In vivo 18F-AV-1451 tau-PET signal in MAPT mutation carriers varies by expected tau isoforms.

Jones DT, Knopman DS, Graff-Radford J, Syrjanen JA, Senjem ML, Schwarz CG, Dheel C, Wszolek Z, Rademakers R, Kantarci K, Petersen RC, Jack CR Jr, Lowe VJ, Boeve BF.

Neurology. 2018 Feb 9. pii: 10.1212/WNL.0000000000005117. doi: 10.1212/WNL.0000000000005117. [Epub ahead of print]

PMID:
29440563
5.

Tau-negative amnestic dementia masquerading as Alzheimer disease dementia.

Botha H, Mantyh WG, Graff-Radford J, Machulda MM, Przybelski SA, Wiste HJ, Senjem ML, Parisi JE, Petersen RC, Murray ME, Boeve BF, Lowe VJ, Knopman DS, Jack CR Jr, Jones DT.

Neurology. 2018 Feb 7. pii: 10.1212/WNL.0000000000005124. doi: 10.1212/WNL.0000000000005124. [Epub ahead of print]

PMID:
29438037
6.

Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer's disease pathogenesis.

Zhou X, Chen Y, Mok KY, Zhao Q, Chen K, Chen Y, Hardy J, Li Y, Fu AKY, Guo Q, Ip NY; Alzheimer’s Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1697-1706. doi: 10.1073/pnas.1715554115. Epub 2018 Feb 5.

7.

Neurogranin as a predictor of memory and executive function decline in MCI patients.

Headley A, DeLeon-Benedetti A, Dong C, Levin B, Loewenstein D, Camargo C, Rundek T, Zetterberg H, Blennow K, Wright CB, Sun X; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2018 Feb 2. pii: 10.1212/WNL.0000000000005057. doi: 10.1212/WNL.0000000000005057. [Epub ahead of print]

PMID:
29429972
8.

Frequency of Acute and Subacute Infarcts in a Population-Based Study.

Arnold Fiebelkorn C, Vemuri P, Rabinstein AA, Mielke MM, Przybelski SA, Kantarci K, Jones DT, Brown RD Jr., Knopman DS, Petersen RC, Jack CR Jr., Graff-Radford J.

Mayo Clin Proc. 2018 Feb 6. pii: S0025-6196(17)30872-8. doi: 10.1016/j.mayocp.2017.11.021. [Epub ahead of print]

PMID:
29426582
9.

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.

Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Marcus DS, Fagan AM, Jack CR Jr, Hornbeck RC, Paumier KL, Ances BM, Berman SB, Brickman AM, Cash DM, Chhatwal JP, Correia S, Förster S, Fox NC, Graff-Radford NR, la Fougère C, Levin J, Masters CL, Rossor MN, Salloway S, Saykin AJ, Schofield PR, Thompson PM, Weiner MM, Holtzman DM, Raichle ME, Morris JC, Bateman RJ, Benzinger TLS.

Lancet Neurol. 2018 Mar;17(3):241-250. doi: 10.1016/S1474-4422(18)30028-0. Epub 2018 Feb 1.

PMID:
29397305
10.

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.

Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP; Alzheimer’s Disease Neuroimaging Initiative (ADNI) Study Group; Neurologic Outcomes Research Group (NORG).

Anesthesiology. 2018 Feb 1. doi: 10.1097/ALN.0000000000002103. [Epub ahead of print]

PMID:
29389750
11.

Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech.

Utianski RL, Whitwell JL, Schwarz CG, Senjem ML, Tosakulwong N, Duffy JR, Clark HM, Machulda MM, Petersen RC, Jack CR Jr., Lowe VJ, Josephs KA.

Cortex. 2018 Feb;99:358-374. doi: 10.1016/j.cortex.2017.12.021. Epub 2018 Jan 2.

PMID:
29353121
12.

Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly.

Fatemi F, Kantarci K, Graff-Radford J, Preboske GM, Weigand SD, Przybelski SA, Knopman DS, Machulda MM, Roberts RO, Mielke MM, Petersen RC, Jack CR Jr, Vemuri P.

Neurology. 2018 Feb 6;90(6):e466-e473. doi: 10.1212/WNL.0000000000004913. Epub 2018 Jan 17.

PMID:
29343465
13.

[18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.

Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML, Schwarz CG, Spychalla AJ, Jones DT, Drubach DA, Knopman DS, Boeve BF, Ertekin-Taner N, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA.

Ann Neurol. 2018 Feb;83(2):248-257. doi: 10.1002/ana.25142. Epub 2018 Feb 6.

PMID:
29323751
14.

CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.

Rojas JC, Bang J, Lobach IV, Tsai RM, Rabinovici GD, Miller BL, Boxer AL; AL-108-231 Investigators.

Neurology. 2018 Jan 23;90(4):e273-e281. doi: 10.1212/WNL.0000000000004859. Epub 2017 Dec 27.

PMID:
29282336
15.

Novel GRN mutation presenting as an aphasic dementia and evolving into corticobasal syndrome.

Botha H, Finch NA, Gavrilova RH, Machulda MM, Fields JA, Lowe VJ, Petersen RC, Jack CR Jr, Dheel CM, Gearhart DJ, Knopman DS, Rademakers R, Boeve BF.

Neurol Genet. 2017 Dec 11;3(6):e201. doi: 10.1212/NXG.0000000000000201. eCollection 2017 Dec. No abstract available.

16.

Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.

Whitwell JL, Ahlskog JE, Tosakulwong N, Senjem ML, Spychalla AJ, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA.

Parkinsonism Relat Disord. 2017 Dec 13. pii: S1353-8020(17)30842-8. doi: 10.1016/j.parkreldis.2017.12.016. [Epub ahead of print]

PMID:
29254665
17.

Longitudinal association between brain amyloid beta and gait in the Mayo Clinic Study of Aging.

Wennberg AMV, Lesnick TG, Schwarz CG, Savica R, Hagen CE, Roberts RO, Knopman DS, Hollman JH, Vemuri P, Jack CR Jr, Petersen RC, Mielke MM.

J Gerontol A Biol Sci Med Sci. 2017 Dec 9. doi: 10.1093/gerona/glx240. [Epub ahead of print]

PMID:
29236984
18.

Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.

Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, Josephs KA, Fang P, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr.

Brain. 2018 Jan 1;141(1):271-287. doi: 10.1093/brain/awx320.

PMID:
29228201
19.

Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia.

Tetzloff KA, Duffy JR, Clark HM, Strand EA, Machulda MM, Schwarz CG, Senjem ML, Reid RI, Spychalla AJ, Tosakulwong N, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL.

Brain. 2018 Jan 1;141(1):302-317. doi: 10.1093/brain/awx293.

PMID:
29228180
20.

Association Between Microinfarcts and Blood Pressure Trajectories.

Graff-Radford J, Raman MR, Rabinstein AA, Przybelski SA, Lesnick TG, Boeve BF, Murray ME, Dickson DW, Reichard RR, Parisi JE, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K.

JAMA Neurol. 2018 Feb 1;75(2):212-218. doi: 10.1001/jamaneurol.2017.3392.

PMID:
29204605

Supplemental Content

Loading ...
Support Center